Alnylam Pharmaceuticals, Inc. ALNY
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.44% | 9.93% | 3.46% | 6.75% | -4.65% |
| Total Receivables | 18.86% | 3.26% | 13.68% | -19.40% | 70.12% |
| Inventory | 9.06% | 15.57% | 1.58% | 9.73% | 5.15% |
| Prepaid Expenses | 10.73% | 24.81% | -14.11% | 49.91% | 27.64% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 10.66% | 9.50% | 4.16% | 2.48% | 8.48% |
|
|
|||||
| Total Current Assets | 10.66% | 9.50% | 4.16% | 2.48% | 8.48% |
| Net Property, Plant & Equipment | 7.51% | 4.23% | -0.07% | 2.15% | 0.14% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 938.89% | -0.78% | -2.37% | 0.92% | -10.61% |
| Total Assets | 43.82% | 8.37% | 3.29% | 2.36% | 6.26% |
|
|
|||||
| Total Accounts Payable | 25.35% | -14.70% | 9.43% | -1.59% | 14.84% |
| Total Accrued Expenses | 12.80% | 15.79% | 15.24% | -28.80% | 25.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 123.20% | 11.48% | 2.85% | 65.53% | 11.72% |
| Total Finance Division Other Current Liabilities | 190.71% | 24.93% | -98.78% | 113.02% | -8.89% |
| Total Other Current Liabilities | 190.71% | 24.93% | -98.78% | 113.02% | -8.89% |
| Total Current Liabilities | 36.40% | 12.08% | -7.97% | -5.73% | 19.57% |
|
|
|||||
| Total Current Liabilities | 36.40% | 12.08% | -7.97% | -5.73% | 19.57% |
| Long-Term Debt | -14.50% | -0.26% | 0.04% | 3.71% | 0.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.42% | -3.45% | -3.14% | 0.75% | -0.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.88% | 20.25% | 0.22% | -98.31% | 7.40% |
| Total Liabilities | 4.43% | 3.71% | -2.94% | -9.54% | 7.01% |
|
|
|||||
| Common Stock & APIC | 1.23% | 1.60% | 1.13% | 1.29% | -3.59% |
| Retained Earnings | 34.23% | 2.53% | 3.07% | 6.39% | 3.39% |
| Treasury Stock & Other | -38.97% | -29.10% | -23.87% | 7.71% | 27.30% |
| Total Common Equity | 166.14% | 25.92% | 36.27% | 237.41% | -6.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 166.14% | 25.92% | 36.27% | 237.41% | -6.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 166.14% | 25.92% | 36.27% | 237.41% | -6.66% |
|
|
|||||